Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?
Clin. biomed. res
;
42(3): 296-298, 2022.
Artículo
en Inglés
| LILACS
| ID: biblio-1416978
ABSTRACT
Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford-AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the dissemination of this case is of paramount importance.
Asunto(s)
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Pitiriasis Rosada
/
Vacunas contra la COVID-19
/
ChAdOx1 nCoV-19
Límite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Clin. biomed. res
Asunto de la revista:
Medicina
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Hospital Santa Casa de Misericórdia de Porto Alegre/BR
/
Irmandade Santa Casa de Misericórdia de Porto Alegre/BR
/
Universidade Federal de Ciências da Saúde de Porto Alegre/BR
/
Universidade Luterana do Brasil/BR
Similares
MEDLINE
...
LILACS
LIS